首页> 外文期刊>British Journal of Cancer >Herpes zoster risk after 21 specific cancers: population-based case–control study
【24h】

Herpes zoster risk after 21 specific cancers: population-based case–control study

机译:基于人群的病例对照研究:21种特定癌症后带状疱疹风险

获取原文
获取外文期刊封面目录资料

摘要

Background: Some malignancies are known to be associated with increased risk of herpes zoster, but little is known about how associations between cancer and subsequent zoster risk vary by cancer site, by time since cancer diagnosis, and by age. Methods: An age-, sex-, calendar time-, and practice-matched case–control study, nested in the broadly UK representative Clinical Practice Research Datalink (CPRD) primary care database, was analysed using conditional logistic regression to estimate the association between 21 of the most common specific malignancies and subsequent zoster risk. We adjusted for comorbid conditions and other potential confounders, and investigated effect modification by age and time since malignancy diagnosis. Results: A total of 192?081 adult zoster patients and 732?035 controls were included. Malignancy overall was positively associated with zoster risk (adjusted OR 1.29, 95% CI 1.27–1.32), and the association was especially strong for haematological malignancies (OR 2.46, 2.33–2.60). Among specific malignancies, there was evidence that oral, oesophageal, stomach, colorectal, lung, breast, ovarian, prostate, kidney, bladder, and CNS cancers, as well as lymphoma, myeloma, and leukaemia were associated with increased zoster odds ( P ?0.05 in each case), but the magnitude of associations varied widely. The association was typically strongest within 2 years of malignancy diagnosis and decreased with older age for both haematological and solid malignancies. Conclusions: Several cancers were associated with an increased risk of zoster, particularly within the first 2 years after diagnosis and among younger individuals. Knowledge that patients with a recent diagnosis of cancer are at high risk of zoster may encourage initiation of antiviral therapy earlier in the course of zoster when the benefits are greater. Evaluation of whether patients diagnosed with cancer would benefit from early zoster vaccination is warranted.
机译:背景:已知某些恶性肿瘤与带状疱疹风险增加有关,但对于癌症与随后带状疱疹风险之间的关联如何因癌症部位,自癌症诊断以来的时间以及年龄而变化的知之甚少。方法:使用条件对数回归分析分析了年龄,性别,日历时间和实践匹配的病例对照研究,该研究嵌套在具有广泛代表性的英国代表性临床实践研究数据链(CPRD)初级保健数据库中。 21种最常见的特定恶性肿瘤及随后的带状疱疹风险。我们对合并症和其他潜在的混杂因素进行了调整,并研究了自恶性肿瘤诊断以来按年龄和时间划分的效果改变。结果:总共包括192-081名成年带状疱疹患者和732-035名对照。总体而言,恶性肿瘤与带状疱疹风险呈正相关(校正后的OR为1.29,95%CI为1.27-1.32),血液学恶性肿瘤的相关性尤其强(OR 2.46、2.33-2.60)。在特定的恶性肿瘤中,有证据表明,口腔癌,食道癌,胃癌,结直肠癌,肺癌,乳腺癌,卵巢癌,前列腺癌,肾脏癌,膀胱癌和中枢神经系统癌以及淋巴瘤,骨髓瘤和白血病与带状疱疹几率增加相关(P?每种情况下均为0.05),但关联程度差异很大。血液学和实体恶性肿瘤的相关性通常在恶性肿瘤诊断的2年内最强,并且随着年龄的增长而降低。结论:几种癌症与带状疱疹风险增加有关,尤其是在诊断后的头两年内以及较年轻的人群中。近期诊断为癌症的患者存在带状疱疹的高风险的认识可能会在益处更大时鼓励在带状疱疹的早期阶段开始抗病毒治疗。有必要评估被诊断患有癌症的患者是否将从早期带状疱疹疫苗接种中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号